Myotonic Dystrophy

Myotonic Dystrophy is an autosomal dominant neuromuscular disorder associated with the expansion of CTG trinucleotide repeats in the 3’ untranslated region of the myotonic dystrophy protein kinase (DMPK) gene. Here is the latest research.

December 30, 2020
Open Access

Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy

International Journal of Molecular Sciences
Hwa Yeon JeongSung-Chun Kim
January 16, 2021
Case Report
Open Access

Transaminitis in a Three-year-old Boy with Duchenne Muscular Dystrophy

Journal of Clinical and Translational Hepatology
Qiuli XieJianqiang Ding
December 12, 2020
Case Report

Silent dysphagia in two patients with Steinert disease and recurrent respiratory exacerbations

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
Anna AnnunziataGiuseppe Fiorentino
January 10, 2021

Simple and Rapid LC-MS/MS Methods for Quantifying Catabolites of Antibody-Drug Conjugates with SMCC Linker

Journal of Chromatographic Science
Li LiHaifeng Song
January 20, 2021

Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1

Muscle & Nerve
Ellen van der PlasPeggy Nopoulos
December 10, 2020
Open Access

Longitudinal Changes of Tongue Thickness and Tongue Pressure in Neuromuscular Disorders

George UmemotoYoshio Tsuboi
January 20, 2021

Cannabidiol induces antidepressant and anxiolytic-like effects in experimental type-1 diabetic animals by multiple sites of action

Metabolic Brain Disease
Yane Costa ChavesJanaína Menezes Zanoveli
January 4, 2021

Differentiating moebius syndrome and other congenital facial weakness disorders with electrodiagnostic studies

Muscle & Nerve
Tanya Lehky“Moebius Syndrome Research Consortium”
January 9, 2021
Open Access

Hyperglycemic levels in early stage of diabetic nephropathy affect differentially renal expression of claudins-2 and -5 by oxidative stress

Life Sciences
Lorena Rosas-MartínezLuz Graciela Cervantes-Pérez
January 21, 2021

Altered REM sleep architecture in patients with Myotonic dystrophy type 1: is related to sleep apnea?

Sleep Medicine
Doniparthi Venkata SeshagiriAtchayaram Nalini
January 2, 2021
Open Access

The impact of «faster aspart» on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump

Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)
Jesús González de Buitrago AmigoMarta Ferrer Lozano
January 13, 2021

In vitro effects of Trastuzumab Emtansine (T-DM1) and concurrent irradiation on HER2-positive breast cancer cells

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
Fabien MignotFrédérique Megnin-Chanet
December 16, 2020

Impact of metabolic surgery on type-2 diabetes remission

Current Diabetes Reviews
Cejana de Abrantes Figueiredo BaiocchiAlberto Krayyem Arbex
December 30, 2020

Effect of exercise training on functional capacity and body composition in myotonic dystrophy type 2 patients

Muscle & Nerve
Eleni KontouGerasimos Terzis
January 14, 2021
Open Access

Is it possible to prevent diabetic ketoacidosis at diagnosis of pediatric type 1 diabetes? Lessons from the COVID-19 pandemic

Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft für Kinderheilkunde
Kirsten MönkemöllerDPV Initiative
January 19, 2021

Myotonic dystrophy type 2: the 2020 update

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
Giovanni Meola

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved